Indomethacin enhances learning and memory potential by interacting with CaMKII

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Cyclooxygenase (COX) inhibitors, like indomethacin (IM), are known for their anti-inflammatory properties.
• The precise mechanisms by which COX inhibitors affect cognitive functions, particularly learning and memory, remain under investigation.

Purpose of the Study:

• To investigate the effects of indomethacin (IM) on learning and memory functions.
• To elucidate the underlying molecular mechanisms involving hippocampal synaptic transmission and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII).

Main Methods:

• Electrophysiological recordings in rat hippocampal slices to assess synaptic transmission and glutamate release.
• In vivo behavioral tests (water maze) in rats and mice to evaluate spatial learning and memory.
• Cognitive tests in healthy human subjects to assess learning and memory after IM administration.

Main Results:

• Indomethacin (IM) increased spontaneous AMPA receptor-mediated miniature excitatory postsynaptic currents and enhanced high K(+)-induced glutamate release in rat hippocampal slices.
• These effects were dependent on Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) activation and were inhibited by KN-93.
• IM administration improved spatial learning and memory in rats and mice, ameliorating impairments induced by scopolamine or aging.
• Human subjects showed enhanced memory recall after IM intake.

Conclusions:

• Indomethacin (IM) enhances learning and memory potential.
• IM facilitates hippocampal synaptic transmission by stimulating presynaptic glutamate release, a process regulated by CaMKII.
• These findings suggest a potential therapeutic role for IM in cognitive enhancement.